Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Caissa Capital Management ltd. Insider Profile
4 Followers
Caissa Capital Management ltd., Ten Percent Owner at Avalo Therapeutics, holds 0.00 shares in Avalo Therapeutics (Ticker: AVTX). Most recently, Caissa Capital Management ltd. Sold $1,608,000 shares of Avalo Therapeutics on Jun 27, 2023 for an estimated value of 1.03M.
Caissa Capital Management ltd. Avalo Therapeutics (AVTX)Ten Percent Owner
Avalo Therapeutics (AVTX)
Ten Percent Owner
Ranked #96,254 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 14 Profitable Transactions
Average Return
-73.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Caissa Capital Management ltd. does not currently own shares as a corporate insider.
A breakdown of Caissa Capital Management ltd.'s holdings
Insider Roles
Ten Percent Owner
Roles that Caissa Capital Management ltd. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Caissa Capital Management ltd.
Caissa Capital Management ltd.'s Trading History
List of latest transactions for each holding click on a transaction to see Caissa Capital Management ltd.'s performance on stock
You May Also Like
Caissa Capital Management ltd. insider profile FAQ
What is the percentage of profitable transactions made by Caissa Capital Management ltd.?
The percentage of profitable transactions made by Caissa Capital Management ltd. is 7%.
What is the average return per transaction made by Caissa Capital Management ltd.?
The average return per transaction made by Caissa Capital Management ltd. is -73.40%.
What stocks does Caissa Capital Management ltd. hold?
Caissa Capital Management ltd. holds: AVTX stocks.
What was Caissa Capital Management ltd.’s latest transaction?
Caissa Capital Management ltd. latest transaction was an Informative Sell of $1.03M.
What was Caissa Capital Management ltd.'s most profitable transaction?
Caissa Capital Management ltd.’s most profitable transaction was an Informative Sell of AVTX stock on June 27, 2023. The return on the trade was 86.00%.
What is Caissa Capital Management ltd.'s role in Avalo Therapeutics?
Caissa Capital Management ltd.'s role in Avalo Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.